VT News

Nina Gantz

Ask VT AI
View News Summary
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Housing crisis persists globally, with public distrust of new construction as a solution, leading to emerging alternatives like build-to-rent single-family rentals and community-led affordable housing models.
  • Colts' Jonathan Taylor rushes for three touchdowns in 38-24 win over Chargers
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Housing crisis persists globally, with public distrust of new construction as a solution, leading to emerging alternatives like build-to-rent single-family rentals and community-led affordable housing models.
  • Colts' Jonathan Taylor rushes for three touchdowns in 38-24 win over Chargers
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Nina Gantz

Top Topics

Trending in U.S.

World

Sport